Letter

Sentinel lymph node biopsy: Not yet standard of care for melanoma

BMJ 2004; 329 doi: 10.1136/bmj.329.7458.170 (Published 15 July 2004)
Cite this as: BMJ 2004;329:170.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. J Meirion Thomas (sarcoma@mac.com), consultant surgical oncologist,
  2. Matthew A Clark, consultant surgical oncologist
  1. Royal Marsden Hospital Melanoma and Sarcoma Unit, London SW3 6JJ

    EDITOR—Kell and Kerin wrote about sentinel lymph node biopsy in breast cancer and melanoma.1 This is a staging procedure with a well established role in breast cancer, reducing the need for dissection of the axillary node. The indications and advantages for sentinel lymph node biopsy in melanoma are not confirmed, and it is certainly not the established …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular